Equities

Fractyl Health Inc

GUTS:NMQ

Fractyl Health Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)2.79
  • Today's Change0.07 / 2.57%
  • Shares traded3.32m
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments334995
Total Receivables, Net0.02----
Total Inventory0.07----
Prepaid expenses2.032.360.92
Other current assets, total0.32----
Total current assets365296
Property, plant & equipment, net311.651.35
Goodwill, net------
Intangibles, net------
Long term investments------
Note receivable - long term------
Other long term assets5.543.434.82
Total assets7661103
LIABILITIES
Accounts payable0.550.980.97
Accrued expenses106.306.86
Notes payable/short-term debt000
Current portion long-term debt/capital leases--016
Other current liabilities, total0.580.040.10
Total current liabilities117.3124
Total long term debt55180
Total debt551816
Deferred income tax------
Minority interest------
Other liabilities, total480.870.89
Total liabilities1142625
SHAREHOLDERS EQUITY
Common stock0.00----
Additional paid-in capital221714
Retained earnings (accumulated deficit)(347)(270)(223)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity(38)3578
Total liabilities & shareholders' equity7661103
Total common shares outstanding484848
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.